Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer's disease by regulating cilia function

被引:69
作者
Hu, Lili [1 ]
Wang, Bingjie [1 ]
Zhang, Yan [1 ]
机构
[1] Peking Univ, PKU IDG McGovern Inst Brain Res, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Room 239, Beijing 100871, Peoples R China
基金
美国国家科学基金会;
关键词
5-HT6; Cilia; Axon; Axon initial segment; Alzheimer's disease; BARDET-BIEDL-SYNDROME; TYPE-3; ADENYLYL-CYCLASE; AXON INITIAL SEGMENT; ASSOCIATION ANALYSIS; POLYMORPHISM C267T; NEURONAL CILIA; RAT-BRAIN; LOCALIZATION; ANTAGONIST; MEMORY;
D O I
10.1186/s13195-017-0304-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Serotonin receptor 5-HT6 is involved in cognition and Alzheimer's disease (AD) development. However, the mechanism of 5-HT6 in AD pathology is not clear. Methods: Since 5-HT6 is almost exclusively expressed in the primary cilia, using immunostaining we examined the number of cilia in the hippocampus of AD animal model APP/PS1 mice. By overexpressing and knocking down 5-HT6 in the primary cultured hippocampal neurons, we investigated the roles of 5-HT6 in alternating ciliary morphology. Furthermore, 5-HT6 antagonist was applied to confirm its roles in cognition using the Morris water maze test, Y maze, and fear conditioning. Results: In the present study, we found that the primary cilia were elongated in the hippocampus of APP/PS1 mice compared with WT mice. 5-HT6 regulated cilia length, influenced cilia and axon initial segment (AIS) morphology, and affected localization of ARL13B and AnkG. We also found that, by changing cilia morphology, the AIS was elongated, branched, and more proximal to the cell body in both WT and APP/PS1 mouse neurons. Alterations of cilia also decreased the axonal length in WT and APP/PS1 neurons. Furthermore, in the water maze test, Y maze, and fear conditioning test, 5-HT6 antagonist SB271046 recovered the cognitive impairment of APP/PS1 mice. Conclusion: We suggest that 5-HT6 plays a critical role in AD development through regulating the morphology and function of neuronal primary cilia, which is possibly related to the AIS and axon alterations in AD development.
引用
收藏
页数:17
相关论文
共 50 条
[31]   IDALOPIRDINE, A 5-HT6 RECEPTOR ANTAGONIST IN DEVELOPMENT FOR THE TREATMENT OF MILD-MODERATE ALZHEIMER'S DISEASE: THE SCIENTIFIC RATIONALE [J].
de Jong, Inge ;
Herrik, Kjartan ;
Helboe, Lone ;
Foraster, Maria Amat ;
Smagin, Gennady ;
Leiser, Steven ;
Ferris, Craig ;
Mork, Arne .
NEUROBIOLOGY OF AGING, 2016, 39 :S12-S12
[32]   Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease [J].
Toublet, Francois-Xavier ;
Lalut, Julien ;
Hatat, Berenice ;
Lecoutey, Cedric ;
Davis, Audrey ;
Since, Marc ;
Corvaisier, Sophie ;
Freret, Thomas ;
Santos, Jana Sopkova-de Oliveira ;
Claeysen, Sylvie ;
Boulouard, Michel ;
Dallemagne, Patrick ;
Rochais, Christophe .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
[33]   Association analysis of the 5-HT6 receptor polymorphism C267T with depression in patients with Alzheimer's disease [J].
Liu, HC ;
Hong, CJ ;
Liu, CY ;
Lin, KN ;
Tsai, SJ ;
Liu, TY ;
Chi, CW ;
Wang, PN .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) :427-429
[34]   COGNITION AND MEMORY FUNCTION OF TARAXACUM COREANUM IN AN IN VIVO AMYLOID-B-INDUCED MOUSE MODEL OF ALZHEIMER'S DISEASE [J].
Lee, Ah Young ;
Yamabe, Noriko ;
Kang, Ki Sung ;
Kim, Hyun Young ;
Lee, Sanghyun ;
Cho, Eun Ju .
ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (04) :1357-1366
[35]   Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity-Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease [J].
Wieckowski, Krzysztof ;
Szalaj, Natalia ;
Gryzlo, Beata ;
Wichur, Tomasz ;
Goral, Izabella ;
Slugocka, Emilia ;
Sniecikowska, Joanna ;
Latacz, Gniewomir ;
Siwek, Agata ;
Godyn, Justyna ;
Bucki, Adam ;
Kolaczkowski, Marcin ;
Wieckowska, Anna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
[36]   Plasmalogen Improves Memory Function by Regulating Neurogenesis in a Mouse Model of Alzheimer's Diseases [J].
Li, Rongzi ;
Xiong, Wei ;
Li, Boying ;
Li, Yixuan ;
Fang, Bing ;
Wang, Xifan ;
Ren, Fazheng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
[37]   Reduction in the neuronal surface of post and presynaptic GABAB receptors in the hippocampus in a mouse model of Alzheimer's disease [J].
Martin-Belmonte, Alejandro ;
Aguado, Carolina ;
Alfaro-Ruiz, Rocio ;
Moreno-Martinez, Ana Esther ;
de la Ossa, Luis ;
Martinez-Hernandez, Jose ;
Buisson, Alain ;
Frueh, Simon ;
Bettler, Bernhard ;
Shigemoto, Ryuichi ;
Fukazawa, Yugo ;
Lujan, Rafael .
BRAIN PATHOLOGY, 2020, 30 (03) :554-575
[38]   AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease [J].
Ivachtchenko, Alexandre V. ;
Lairrovsky, Yan ;
Ivanenkov, Yan A. .
MOLECULAR PHARMACEUTICS, 2016, 13 (03) :945-963
[39]   Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View? [J].
Czarnota-Lydka, Kinga ;
Kucwaj-Brysz, Katarzyna ;
Pyka, Patryk ;
Haberek, Wawrzyniec ;
Podlewska, Sabina ;
Handzlik, Jadwiga .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
[40]   Activation and blockade of basolateral amygdala 5-HT6 receptor produce anxiolytic-like behaviors in an experimental model of Parkinson's disease [J].
Sun, Yi-Na ;
Yao, Lu ;
Li, Li-Bo ;
Wang, Yong ;
Du, Cheng-Xue ;
Guo, Yuan ;
Liu, Jian .
NEUROPHARMACOLOGY, 2018, 137 :275-285